Nutriband Inc. (OTC:NTRB)
Industry: Biotechnology

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Current Quote*
Last: $8.070
Change: -1.000
Book: $3.360
Volume: 389,277

As Of: 09/25 16:08 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol NTRB

Graphs for NTRB


3 Month Graph


6 Month Graph


1 Year Graph